Stand aside — setup invalidated
Setup score 83, but distribution days reach 5 or more — stand aside until the condition resets.
Simple research view
INCY · Incyte Corporation
$116.80 -0.06% Oct 29 close
1 independent risk warning also present. Review before relying on the bullish setup.
Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.
$INCY
Incyte CorporationIncyte Corporation is a large-cap Pharmaceuticals: Major company in the Health Technology sector with a market cap of $24B.
⚠ Risk Signals
Double Top
Double Top (confirmed): peaks $130.00 and $128.72 (2026-09-18) with the neckline at $119.97. neckline $119.97 broken on a closing basis 20 bars ago. Measured move targets $110.58; invalidation above $132.60. Research/educational only, not a buy/sell recommendation.
Bearish structure on the daily chart — a heads-up for anyone holding, not a short signal. Does not affect the bullish setup score.
Market Structure
Trend structure: downtrend
Latest event: bos
(bearish)
Support
99.44–100.30
· 5 touches · strong
Support
102.67–103.45
· 4 touches · moderate
Support
93.54–94.10
· 3 touches · moderate
Support
98.40–98.85
· 3 touches · moderate
Resistance
118.97–119.97
· 3 touches · moderate
Momentum Turn Watch
Bollinger Squeeze
Bollinger band width (7.7%) is in the bottom quartile of its last 120 sessions — Legend's width-percentile squeeze (not a TTM/Keltner squeeze), so volatility is compressed and a sharper move often follows.
Early technical context only. Wait for price, volume, and the canonical setup trigger to confirm; this signal does not change readiness or the setup score.
Historical verdict · setup score 83/100 · data Oct 29 close · latest session
Stand aside — setup invalidated
Setup score 83, but distribution days reach 5 or more — stand aside until the condition resets.
Recent price action · daily
What would change this verdict
What needs to turn for this to become buyable — the top failing checks across the legend council:
- Minervini 1.5 Price > 50-day MA — Price $116.80 vs MA50 $120.62
- O'Neil M: Market in confirmed uptrend — Market phase: uptrend_under_pressure
- O'Neil I: Institutional sponsorship
- Weinstein Weekly price coiling (Stage 2 consolidation) — Tightening weekly range confirms base
- Dennis S1: 20-day Donchian breakout
- Dennis S2: 55-day Donchian breakout
Minority view — the council disagrees here
- Minervini: avoid Trend-template read: fails Price > 50-day MA.
- O'Neil: watch CANSLIM read: 6/8 pass; improvement is still needed.
- Weinstein: watch Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.
62
Neutral
Legend Score · rates the stock
Neutral (62/100) — held back by eps growth
Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.
- Relative Strength (25%) 84
- Trend Template (25%) 88
- Institutional Footprint (20%) 38
- EPS Growth (15%) 31
- Quality (SMR-like) (15%) 44
RS rank 83: beating most of the market. Trend template 7/8: price above rising 50/150/200-day lines — textbook uptrend structure. Institutional score 38: mild distribution — sellers active. EPS up +1% — growing, but below the 25% leadership bar. Quality 44: weak fundamentals (sales growth 30, return on equity 41, leverage 100). Updated 2026-09-30.
Earnings
Post-earnings setup
Next earnings
Thursday, October 29, 2026
Before market open
Exact clock time not supplied by source
Deterministic evidence
INCY-0.06%
CatalystUnavailable
Stock reactionNegative
Sector reactionUnavailable
Opening surgeNo surge
Event riskEarnings-driven
Session internals Mixed
Rule: direction and internals disagree — it met neither the strong nor the weak rule. Judged on internals, not on the size of the move.
Vs prior close-0.06%
From the open+4.62%
Range position95%
GapFaded
Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.
More stats
52W Low
$88.20
Tight Wks
0
Base
B3
SMA 200
$107.99
RS Line vs High
-8.1%
RS Line Slope
-1.8% ▼
Group Rank
#14/69
ADR%
3.0%
ATR(14)
$3.67 (3.1%)
Vol Pace (live)
N/A
A/D Days
9A / 15D
A/D Rating
E
VDU Bars
0/10 d
Earnings
past
INCY Chart
Interactive price, volume, RS, RSI, and MACD charts are available after sign in.
Technical Analysis Report Card
$INCY · $116.80 · as of 2026-10-29 · multi-factor read
72
/ 100
Reference read from price & volume only — the verdict at the top of the page decides the action.
Trend · Daily / Weekly / Monthly
Daily
▬ Sideways / consolidating
Weekly
▬ Sideways / consolidating
Monthly
▬ Sideways / consolidating
Moving Averages
50-day$120.62 ↓
100-day$117.95 ↓
200-day$107.99 ↑
Bullish (50 > 200)
RSI (14)
Reading50.6 · Neutral
Neutral — momentum is balanced between buyers and sellers.
MACD (12/26/9)
StateImproving
Histogram+0.767
Improving — MACD crossed above its signal line but still below zero. Histogram expanding.
Bollinger Bands (20,2)
%B / Width83% · 7.7%
Squeeze — volatility compressing
Near the upper band — buyers in control. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.
Volume · Buyer vs Seller
Up/Down vol0.94 · Neutral
Rel volume1.89×
Pocket pivots · 10d0
5d vs 50d vol142%
Heavy vol up / down0 / 2
Balanced — up/down volume is roughly even; no clear hand. Recent volume is expanding versus its baseline.
- 2 heavy-volume down days vs 0 up in the last 20 sessions — supply is showing.
Support & Resistance
R · $119.28swing level
R · $130.08swing level
R · $132.6052-week high
Price · $116.80now
S · $115.77swing level
S · $110.56swing level
S · $107.78swing level
Fibonacci · Uptrend swing
23.6%$123.06
38.2% ◄ price here$117.16
50.0%$112.39
61.8%$107.62
78.6%$100.83
Retracement support zones measured from the recent swing low up to the high.
The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for INCY — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Above 200-day MA50/200 bullishRS 83 (leader)
Want this read in a legend's voice?
Ask a Legend about INCY
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts
6 methodology checks
Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
How to read the numbers: the setup score (83/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.
Council consensus:
7 of 9 legends are Watching — building, not yet a confirmed buy.
Minervini
Avoid
A
Trend-template read: fails Price > 50-day MA.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $116.80, MA150 $110.86, MA200 $107.99
1.2 150-day MA > 200-day MAMA150 $110.86 vs MA200 $107.99
Failing evidence
1.5 Price > 50-day MAPrice $116.80 vs MA50 $120.62
O'Neil
Watch
B
CANSLIM read: 6/8 pass; improvement is still needed.
Passing evidence
C: Quarterly EPS acceleration ≥ 25%+70.7% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 83
Failing evidence
M: Market in confirmed uptrendMarket phase: uptrend_under_pressure
I: Institutional sponsorshipData unavailable
Weinstein
Watch
B
Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.
mediumClassic Stage 2 advancing phase — strong weekly trend confirms uptrend. This is Weinstein's sweet spot: buy and hold while price remains above the 30-week MA.
Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $116.80 vs MA200 $107.99
Failing evidence
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
dennis
Watch
B
Turtle read: no Donchian signal. The system stays flat until price takes out the 20-day high.
Passing evidence
No breakdown below the 20-day channel20-day low $107.78
Volatility-unit sizing (1N ≈ 1% of equity)1N = $3.54 (3.03% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk
Failing evidence
S1: 20-day Donchian breakoutNot confirmed
S2: 55-day Donchian breakoutNot confirmed
zanger
Avoid
B
Zanger read: a hard gate is broken — either the pattern is not one of his six, or the entry is more than 5% past the breakout. He would not touch this.
Passing evidence
Not extended (≤5% above the breakout point)Measured as passing
Partial-profit plan: sell 20-30% at +15-20%Scale 20-30% at $134.32-$140.16; trail the rest
Failing evidence
Named Zanger pattern onlyWyckoff SOS is not one of Zanger's six
zweig
Watch
B
Zweig read: part of his screen passes but not all: Insider buying — wait for the full growth screen before treating this as a Zweig setup.
Passing evidence
EPS growth above the market (≥15% QoQ)+70.7% QoQ — Zweig wants growth above the S&P average
Reasonable price for the growth (P/E ≤ 35)Trailing P/E 18.2x — no PEG or forward P/E stored
Failing evidence
Insider buyingNo insider buying flagged
Monetary conditions: don't fight the FedFed series stored but too thin to read direction
Livermore
Watch
B
Pivotal-point read: 5/6 structural checks pass; awaiting volume confirmation.
Passing evidence
Price$116.80
Relative strengthRS 83
Failing evidence
Pivotal point cleared on expanding volumeNot confirmed
Darvas
Watch
B
Box-theory read: 5/6 structural checks pass; awaiting volume confirmation.
mediumBuilding the top of the box (7.1% from 52W high) — watch for a box breakout with volume expansion.
Passing evidence
Price$116.80
Relative strengthRS 83
Failing evidence
Box top broken on heavy volumeNot confirmed
Wyckoff
Watch
B
Supply-and-demand read: 5/6 structural checks pass; awaiting volume confirmation.
mediumSign of Strength — breakout above trading range on expanding volume. Accumulation phase complete, markup beginning. RS 83.
Passing evidence
Price$116.80
Relative strengthRS 83
Failing evidence
Sign of Strength confirmed on expanding volume1.89x average volume — needs ≥1.4x
Base & Breakout
Breakout follow-through
No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?
RS Line vs SPY
52-week relative strength · blue = RS line · dashed = MA50 · dot = NH
▼ Falling
Accumulation / Distribution
last 65 sessions · green = acc on high vol · red = dist on high vol
Net -2
Fundamentals & leadership quality — Minervini’s published criteria · 7/7 met
A+
7/7 criteria
Separate score from the Minervini Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
+71%
Revenue growth ≥20% YoY
+21%
Gross margin ≥30%
93%
ROE ≥17%
30%
RS rating ≥80 (leadership)
83
Stage 2 uptrend (Weinstein)
Stage 2
Within 25% of 52W high
-11.9%
Method Playbook
Trade it like Zanger
EXACT LEVELS · PRO
Zanger B · Avoid — The deterministic methodology check is Avoid; wait until the blocking criteria are resolved.
Pivot
Pro levelPublished-method rule: Use the breakout point of a named pattern (flat base, bull flag, ascending triangle, cup and handle, double bottom, symmetrical triangle).
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro levelPublished-method rule: Buy the breakout day on 150-200% of average volume. Never pay more than 5% above the breakout point.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro levelPublished-method rule: Set the stop 2-3% below entry and sell on bad price action before it is even hit.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-basedPublished-method rule: Sell 20-30% of the position at +15-20% from the breakout, then trail the rest on the 10/20-day moving average.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro levelPublished-method rule: Out on a break of the 10/20-day MA, a failed breakout back below the pivot, or a reversal pattern — winners are held, laggards are sold fast.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →
Pattern Analysis (historical)
Wyckoff SOS
Historical replay: +20% before −8% within 40 sessions: 15% (n=225) · source bars 2024-11-01–2026-10-26 · avg +0.3% per setup (+0.04R)
⚠ 3rd-stage base
83
setup score
RS Score
83
Trend template
7/8
CANSLIM
85.2* (B)
range low: 94.743
range high: 118.654
range pct: 0.252
sos thrust: 0.056
sos vol ratio: 2.102
sos bars ago: 7
near lps: ✓
validation reason: valid generic setup
multi tf evaluated: ✓
multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup?
Wyckoff SOS · schematic
SOS: breakout above range_high=118.65, thrust=5.6%, vol=2.1x avg, lps=near, 7 bars ago | Strong trend (7/8) | Top RS (83) | High-confidence pattern (95%) | Stage 2 | Readiness 79/100 (watch) | CANSLIM 85.2 (B) | ⚠ 3rd-stage base
The Universal Edge Check · context only
What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.
5/7
universals met
- Clear of earnings — not met in -1 days — event risk
- A relative-strength leader — partly met RS rank 65 — middling
- Asymmetric reward — met Met — levels are a Pro detail
- In a confirmed uptrend — met Stage 2 · Trend template 7/8
- Not chasing (in range) — met Met — levels are a Pro detail
- Risk is defined — met Met — levels are a Pro detail
- Volume confirms — met 1.1× average
Minervini Trend Template
7/8Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.
Price above SMA 150 & 200
$116.80 vs SMA150 $110.86 / SMA200 $107.99
SMA 150 above SMA 200
SMA150 $110.86 vs SMA200 $107.99
SMA 200 trending up
Slope +1.22 over 20 days
SMA 50 above SMA 150 & 200
SMA50 $120.62
Price above SMA 50
$116.80 vs SMA50 $120.62
30%+ above 52-week low
+32.4% from $88.20
Within 25% of 52-week high
-11.9% from $132.60
RS score above 70
RS 83
Fundamentals
52W Range
64%
Mkt Cap SEC
23.8B
EPS QoQ
+71%
Rev YoY
+21%
ROE
30%
Gross Margin
93%
D/E
0.01
EPS TTM
$6.41
P/E TTM
18.2x
Float
204M
Insider
No Buy
Company
Company profile
Incyte Corporation
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B
85.2* CANSLIM
* disqualified on M
C · Curr. EPS
100
A · Annual EPS
84
N · New Highs
100
S · Supply/Demand
100
L · Leader RS
83
I · Inst. Spons.
100
M · Market
30
Weekly Context
Multi-timeframe signals from weekly barsW. Trend
8/8
W. RS
76
W. Support
$90.08
W. Resist
$132.60
Weekly Structure
Trend
Neutral
Tight Weeks
0
Confirmation
Neutral
Scan History
Sep 30
Wyckoff SOS
83
Sep 29
Wyckoff SOS
✓ Gate
73
-5.2%
Sep 28
Trend Only
✓ Gate
82
-6.4%
Sep 25
Wyckoff SOS
✓ Gate
71
-5.7%
Latest News
Headlines for INCYLoading headlines…
Get the full picture on INCY
Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.
Start 7-Day Free Trial